Back to top

Analyst Blog

On Mar 11, we have updated our research report on Mindray Medical International Limited (MR - Analyst Report). MR continued to see strong international sales, while the domestic market is expected to show gradual improvement in the near future.

MR delivered positive earnings surprise in each of the last four quarters, with an average beat of 18.5%. The company posted an 18.4% rise in adjusted earnings per share to 58 cents for the fourth quarter of 2013 and topped the Zacks Consensus Estimate by 8 cents per share.

Net revenue grew 16.5% to $368.4 million, lying above the Zacks Consensus Estimate of $348.0 million. International revenues grew 23.8% to $208.0 million while revenues from China grew at a slower pace of 8.3% to $160.4 million due to delays in purchasing activities.

MR expects 2014 net revenues to grow at least 15% over 2013 based on strengths in Western Europe and some emerging markets as well as gradual improvement in China.

New products contribute in a major way to Mindray’s revenues. Further, the company has the largest customer support and service team for medical devices in China. This enables MR to provide technical support, training, warranty, maintenance and repair services to end users as well as distributor support.

Currently, MR retains a Zacks Rank #2 (Buy).

Other Stocks to Pick

Other players in the medical instruments sector that are currently worth a look include Cynosure Inc. (CYNO - Snapshot Report), Natus Medical Inc. (BABY - Snapshot Report), and Syneron Medical Ltd. (ELOS - Snapshot Report). All of them sport a Zacks Rank #1 (Strong Buy).
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%